Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting Phase 4 400,000 target

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Jonsson Comprehensive Cancer Center

NCT06934239

Recruiting 75,000 target

TrialNet Pathway to Prevention of T1D

University of South Florida

NCT00097292

Recruiting NA 40,000 target

Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

University of Washington

NCT06768814

Recruiting NA 22,000 target

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

University of Colorado, Denver

NCT05832307

Recruiting 20,000 target

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

Viome

NCT06381232

Recruiting NA 17,800 target

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Swedish Medical Center

NCT07108660

Recruiting NA 13,000 target

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Washington University School of Medicine

NCT05991453

Recruiting 10,000 target

A Prospective Total Joint Surgery Registry to Monitor Short- and Long-Term Clinical Outcomes

Spokane Joint Replacement Center

NCT06687109

Recruiting 10,000 target

Late Onset Alzheimer's Disease

Columbia University

NCT05010603

Recruiting 10,000 target

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Azienda Ospedaliero-Universitaria Careggi

NCT05363657

Recruiting NA 8,000 target

A Comprehensive Trauma-sensitive Approach to Physical Activity Promotion in Schools (CSPAP-T)

Seattle Children's Hospital

NCT05382975

Recruiting 7,500 target

MYLUNG Consortium Part 3: Observational Study

US Oncology Research

NCT05885698

Recruiting Phase 3 6,700 target

Pediatric Dose Optimization for Seizures in Emergency Medical Services

Stanford University

NCT05121324

Recruiting Phase 3 6,150 target

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Population Health Research Institute

NCT04774159

Recruiting 5,179 target

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

Kestra Medical Technologies

NCT05135403

Recruiting 5,000 target

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Michael Shy

NCT01193075

Recruiting 5,000 target

Cardiogenic Shock Working Group Registry

Tufts Medical Center

NCT04682483

Recruiting 5,000 target

ColoCare Study - Colorectal Cancer Cohort

University of Utah

NCT02328677

Recruiting 5,000 target

Functional Assessment in Liver Transplantation

University of California, San Francisco

NCT03228290

Recruiting 5,000 target

Collection of Tissue Samples for Cancer Research

National Cancer Institute (NCI)

NCT00900198

Recruiting 5,000 target

A Crowd Sourcing Platform for Patients With Cancer

All4Cure

NCT03530826

Recruiting 5,000 target

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Boston Scientific Corporation

NCT03664609

Recruiting 5,000 target

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

University of Colorado, Denver

NCT05052606

Recruiting 5,000 target

The Parkinson's Genetic Research Study

University of Washington

NCT01558479

Recruiting NA 4,700 target

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

VA Office of Research and Development

NCT05486572

Recruiting NA 4,200 target

First Responder Airway & Compression Rate Trial

University of Washington

NCT05969028

Recruiting NA 4,165 target

Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail

University of Washington

NCT06593353

Recruiting NA 4,000 target

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Seattle Institute for Biomedical and Clinical Research

NCT05718102

Recruiting Phase 4 3,720 target

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

Daniel Merenstein

NCT06076304

Recruiting NA 3,500 target

The Tick App: Changing Behaviors With Educational Messaging

University of Wisconsin, Madison

NCT06880692

Recruiting Phase 2 3,400 target

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Centers for Disease Control and Prevention

NCT03474029

Recruiting 3,291 target

Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

Duke University

NCT06815536

Recruiting Phase 4 3,200 target

Individualizing Treatment for Asthma in Primary Care (Full Study)

DARTNet Institute

NCT07052942

Recruiting NA 3,090 target

The ED-AWARENESS-2 Trial

Washington University School of Medicine

NCT05534243

Recruiting 3,000 target

Prostate Active Surveillance Study

University of Washington

NCT00756665

Recruiting NA 3,000 target

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Children's Hospital of Philadelphia

NCT05838690

Recruiting NA 3,000 target

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

University Medical Center Nijmegen

NCT04294927

Recruiting 3,000 target

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00067054

Recruiting NA 2,674 target

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

University of Utah

NCT05471908

Recruiting 2,600 target

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Duke University

NCT06399302

Recruiting NA 2,500 target

Study of Student Flourishing

Flourish Science

NCT07259746

Recruiting 2,500 target

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

New York Medical College

NCT02249923

Recruiting 2,460 target

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Fred Hutchinson Cancer Center

NCT06922188

Recruiting NA 2,300 target

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Massachusetts General Hospital

NCT05237258

Recruiting 2,230 target

Genetic Collection Protocol

Arbor Research Collaborative for Health

NCT05272319

Recruiting 2,000 target

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Children's Hospital Medical Center, Cincinnati

NCT04098445

Recruiting 2,000 target

Rare and Atypical Diabetes Network

University of South Florida

NCT05544266

Recruiting 2,000 target

Pacific Northwest Udall Center (PANUC) Clinical Core

University of Washington

NCT01720810

Recruiting Phase 3 2,000 target

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Regeneron Pharmaceuticals

NCT07213778

Recruiting 2,000 target

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

University of Washington

NCT06295965

Recruiting 2,000 target

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome

Seattle Children's Hospital

NCT05008744

Recruiting 2,000 target

CHronic Nonbacterial Osteomyelitis International Registry

Seattle Children's Hospital

NCT04725422

Recruiting 2,000 target

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Case Western Reserve University

NCT00288119

Recruiting 2,000 target

Modifiable Variables in Parkinsonism (MVP)

Bastyr University

NCT02194816

Recruiting NA 2,000 target

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

Accelerated Cure Project for Multiple Sclerosis

NCT06441617

Recruiting 2,000 target

Precision-Based Genomics in Prostate Cancer

National Cancer Institute (NCI)

NCT04706663

Recruiting NA 1,800 target

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

University of Washington

NCT05286931

Recruiting NA 1,800 target

Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers

University of Washington

NCT05596760

Recruiting Phase 4 1,710 target

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Insud Pharma

NCT05303636

Recruiting 1,600 target

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Duke University

NCT03511118

Recruiting NA 1,530 target

Optimal Ventilation for Cardiac Arrest

Children's Hospital of Philadelphia

NCT07114510

Recruiting 1,500 target

Longitudinal Study of Urea Cycle Disorders

Andrea Gropman

NCT00237315

Recruiting NA 1,500 target

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

University Hospital, Basel, Switzerland

NCT03513614

Recruiting 1,500 target

Longitudinal Study of the Porphyrias

Icahn School of Medicine at Mount Sinai

NCT01561157

Recruiting 1,500 target

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

University of Washington

NCT01050504

Recruiting NA 1,500 target

Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment

Kaiser Permanente

NCT06318026

Recruiting Phase 3 1,410 target

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pfizer

NCT07222566

Recruiting Phase 4 1,404 target

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

University of Utah

NCT05444582

Recruiting 1,400 target

HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)

University of Utah

NCT00670735

Recruiting Phase 3 1,380 target

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Merck Sharp & Dohme

NCT06651281

Recruiting 1,265 target

Biliary Atresia Study in Infants and Children

Arbor Research Collaborative for Health

NCT00345553

Recruiting 1,200 target

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

University of Michigan Rogel Cancer Center

NCT00843375

Recruiting Phase 1 1,200 target

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Merck Sharp & Dohme

NCT02861573

Recruiting Phase 3 1,100 target

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

University of Alabama at Birmingham

NCT05638581

Recruiting 1,060 target

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

University of Cincinnati

NCT05911568

Recruiting Phase 2 1,050 target

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

Jason Sperry

NCT05958342

Recruiting 1,050 target

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

University of Iowa

NCT01193088

Recruiting 1,000 target

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Columbia University

NCT01694940

Recruiting 1,000 target

Neuroblastoma Biology Study

New Approaches to Neuroblastoma Therapy Consortium

NCT01587300

Recruiting 1,000 target

Complementary and Alternative Care in Multiple Sclerosis

Bastyr University

NCT01703429

Recruiting 1,000 target

Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)

Debra Weese-Mayer

NCT03568669

Recruiting 1,000 target

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Target ALS Foundation

NCT05137665

Recruiting Phase 3 1,000 target

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Olema Pharmaceuticals

NCT07085767

Recruiting 1,000 target

A Prospective Database of Infants With Cholestasis

Arbor Research Collaborative for Health

NCT00061828

Recruiting Phase 3 1,000 target

A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Eli Lilly and Company

NCT07202884

Recruiting 1,000 target

Primary Sclerosing Cholangitis in Children

Arbor Research Collaborative for Health

NCT04181138

Recruiting NA 1,000 target

First Face Training Evaluation in Tribal Communities

Cambridge Health Alliance

NCT05998005

Recruiting 1,000 target

Psorcast Mobile Study

Sage Bionetworks

NCT05621369

Recruiting Phase 2 982 target

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

NCT06989437

Recruiting Phase 2 960 target

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

GlaxoSmithKline

NCT07204964

Recruiting NA 947 target

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

Mayo Clinic

NCT06087224

Recruiting Phase 1 940 target

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

Hoffmann-La Roche

NCT03075696

Recruiting Phase 3 940 target

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Novartis Pharmaceuticals

NCT06855277

Recruiting Phase 1 933 target

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Regeneron Pharmaceuticals

NCT04626635

Recruiting 900 target

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Tempus AI

NCT07211178

Recruiting NA 900 target

FAmily Engagement Strategy for Coordinated Specialty Care

Washington State University

NCT06945055

Recruiting Phase 2 840 target

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

AbbVie

NCT06236438

Recruiting 820 target

MDR - PMCF Study for Taperloc Complete Stems

Zimmer Biomet

NCT04028687

Recruiting NA 800 target

Effectiveness of Remote Foot Temperature Monitoring

VA Office of Research and Development

NCT05728411

Recruiting 800 target

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Children's Hospital Medical Center, Cincinnati

NCT05750498

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →